Literature DB >> 21735390

Dressings for the prevention of surgical site infection.

Jo C Dumville1, Catherine J Walter, Catherine A Sharp, Tamara Page.   

Abstract

BACKGROUND: Surgical wounds (incisions) heal by primary intention when the wound edges are brought together and secured - often with sutures, staples, clips or glue. Wound dressings, usually applied after wound closure, provide physical support, protection from bacterial contamination and absorb exudate. Surgical site infection (SSI) is a common complication of surgical wounds that may delay healing.
OBJECTIVES: To evaluate the effects of wound dressings for preventing SSI in people with surgical wounds healing by primary intention. SEARCH STRATEGY: We searched the Cochrane Wounds Group Specialised Register (searched 10 May 2011); The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011 Issue 2); Ovid MEDLINE (1950 to April Week 4 2011); Ovid MEDLINE (In-Process & Other Non-Indexed Citations, May 9, 2011); Ovid EMBASE (1980 to 2011 Week 18); EBSCO CINAHL (1982 to 6 May 2011). There were no restrictions based on language or date of publication. SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing alternative wound dressings or wound dressings with leaving wounds exposed for postoperative management of surgical wounds healing by primary intention. DATA COLLECTION AND ANALYSIS: Two review authors performed study selection, risk of bias assessment and data extraction independently. MAIN
RESULTS: Sixteen RCTs were included (2578 participants). All trials were at unclear or high risk of bias. Nine trials included people with wounds resulting from surgical procedures with a contamination classification of 'clean', two trials included people with wounds resulting from surgical procedures with a 'clean/contaminated' contamination classification and the remaining trials evaluated people with wounds resulting from various surgical procedures with different contamination classifications. Two trials compared wound dressings with leaving wounds exposed. The remaining 14 trials compared two alternative dressing types. No evidence was identified to suggest that any dressing significantly reduced the risk of developing an SSI compared with leaving wounds exposed or compared with alternative dressings in people who had surgical wounds healing by secondary intention. AUTHORS'
CONCLUSIONS: At present, there is no evidence to suggest that covering surgical wounds healing by primary intention with wound dressings reduces the risk of SSI or that any particular wound dressing is more effective than others in reducing the rates of SSI, improving scarring, pain control, patient acceptability or ease of dressing removal. Most trials in this review were small and of poor quality at high or unclear risk of bias. However, based on the current evidence, we conclude that decisions on wound dressing should be based on dressing costs and the symptom management properties offered by each dressing type e.g. exudate management.

Entities:  

Mesh:

Year:  2011        PMID: 21735390     DOI: 10.1002/14651858.CD003091.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  10 in total

1.  Postoperative wound dealing and superficial surgical site infection in open radical prostatectomy.

Authors:  Fukashi Yamamichi; Katsumi Shigemura; Mauso Yamashita; Kazushi Tanaka; Soishi Arakawa; Masato Fujisawa
Journal:  Int Wound J       Date:  2014-09-04       Impact factor: 3.315

2.  Local Sustained Delivery of 25-Hydroxyvitamin D3 for Production of Antimicrobial Peptides.

Authors:  Jiang Jiang; Guojun Chen; Franklin D Shuler; Chi-Hwa Wang; Jingwei Xie
Journal:  Pharm Res       Date:  2015-03-14       Impact factor: 4.200

3.  Feasibility work to inform the design of a randomized clinical trial of wound dressings in elective and unplanned abdominal surgery.

Authors: 
Journal:  Br J Surg       Date:  2016-08-04       Impact factor: 6.939

4.  Developing outcome measures assessing wound management and patient experience: a mixed methods study.

Authors:  Daisy Elliott
Journal:  BMJ Open       Date:  2017-11-26       Impact factor: 2.692

Review 5.  Patient engagement with surgical site infection prevention: an expert panel perspective.

Authors:  E Tartari; V Weterings; P Gastmeier; J Rodríguez Baño; A Widmer; J Kluytmans; A Voss
Journal:  Antimicrob Resist Infect Control       Date:  2017-05-12       Impact factor: 4.887

6.  Bluebelle pilot randomised controlled trial of three wound dressing strategies to reduce surgical site infection in primary surgical wounds.

Authors:  Jane Blazeby
Journal:  BMJ Open       Date:  2020-01-12       Impact factor: 2.692

7.  Prevention of Surgical Site Infections in Neonates and Children: Non-Pharmacological Measures of Prevention.

Authors:  Aniello Meoli; Lorenzo Ciavola; Sofia Rahman; Marco Masetti; Tommaso Toschetti; Riccardo Morini; Giulia Dal Canto; Cinzia Auriti; Caterina Caminiti; Elio Castagnola; Giorgio Conti; Daniele Donà; Luisa Galli; Stefania La Grutta; Laura Lancella; Mario Lima; Andrea Lo Vecchio; Gloria Pelizzo; Nicola Petrosillo; Alessandro Simonini; Elisabetta Venturini; Fabio Caramelli; Gaetano Domenico Gargiulo; Enrico Sesenna; Rossella Sgarzani; Claudio Vicini; Mino Zucchelli; Fabio Mosca; Annamaria Staiano; Nicola Principi; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-06-27

8.  Negative Pressure Wound Therapy on Surgical Site Infections in Women Undergoing Elective Caesarean Sections: A Pilot RCT.

Authors:  Wendy Chaboyer; Vinah Anderson; Joan Webster; Anne Sneddon; Lukman Thalib; Brigid M Gillespie
Journal:  Healthcare (Basel)       Date:  2014-09-30

9.  Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: A randomised controlled trial.

Authors:  S L Karlakki; A K Hamad; C Whittall; N M Graham; R D Banerjee; J H Kuiper
Journal:  Bone Joint Res       Date:  2016-08       Impact factor: 5.853

Review 10.  Nanomaterials for Wound Dressings: An Up-to-Date Overview.

Authors:  Alexandra Elena Stoica; Cristina Chircov; Alexandru Mihai Grumezescu
Journal:  Molecules       Date:  2020-06-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.